OGT offers demo version of Genefficiency NGS Variant Analysis Report software for researchers

Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, is offering the research community a snapshot of its user-friendly Genefficiency™ NGS Variant Analysis Report software, with the release of a free-to-download demo version. The interactive report efficiently manages the complete data analysis process for NGS workflows and delivers fully annotated data, allowing the identification of meaningful results in just a few simple mouse clicks.

The demo allows researchers to explore the easy-to-use features of the software with publicly-available sequence data from Tariq et al (2011)1, which identified a novel candidate gene (SHROOM3) for heterotaxy, a severe form of congenital heart disease. It provides researchers with a unique opportunity to experience the interactive report format, discovering what’s possible with OGT’s Genefficiency NGS Services. The report offers rapid filtering options, built-in quality control metrics and the ability to retrospectively analyse the data with additional or new selection criteria.

On completion of all OGT Genefficiency NGS exome and targeted panel projects, customers receive their results pre-loaded into the Genefficiency NGS Variant Analysis Report, so that they can quickly and easily identify relevant data. OGT’s services cover the complete NGS pipeline, from project conception through to the delivery of high-quality, meaningful results via the software, bypassing the bottleneck of complex data analysis.

The Genefficiency NGS Variant Analysis Report is an intuitive solution to NGS data analysis and reporting. Thousands of variations can be filtered within minutes to just a handful requiring further validation — with no requirement for additional bioinformatics resources. Bespoke analysis is easily integrated into the reporting software, allowing variants to be filtered based on biological function or other tailored criteria, for the easy identification of the most significant regions of genetic variation relevant to each individual study. Furthermore, the readily accessible in-depth quality metrics provide maximum confidence that the results are of the highest quality.

Source: http://www.ogt.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oxford Gene Technology. (2013, July 24). OGT offers demo version of Genefficiency NGS Variant Analysis Report software for researchers. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20130724/OGT-offers-demo-version-of-Genefficiency-NGS-Variant-Analysis-Report-software-for-researchers.aspx.

  • MLA

    Oxford Gene Technology. "OGT offers demo version of Genefficiency NGS Variant Analysis Report software for researchers". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20130724/OGT-offers-demo-version-of-Genefficiency-NGS-Variant-Analysis-Report-software-for-researchers.aspx>.

  • Chicago

    Oxford Gene Technology. "OGT offers demo version of Genefficiency NGS Variant Analysis Report software for researchers". News-Medical. https://www.news-medical.net/news/20130724/OGT-offers-demo-version-of-Genefficiency-NGS-Variant-Analysis-Report-software-for-researchers.aspx. (accessed November 22, 2024).

  • Harvard

    Oxford Gene Technology. 2013. OGT offers demo version of Genefficiency NGS Variant Analysis Report software for researchers. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20130724/OGT-offers-demo-version-of-Genefficiency-NGS-Variant-Analysis-Report-software-for-researchers.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia